Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab and vasoconstriction
NL-OMON33520Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of bevacizumab, sponsored by Radboud University Medical Center. Started Jun 2009; status: active, not recruiting.
02
Drugs
bevacizumab
Beyond the preview
Go deeper on NL-OMON33520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33520.